HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxic respiratory distress potentially secondary to phosphorus trifluoride gas exposure.

Abstract
We herein report a rare, probable exposure of a patient to phosphorus trifluoride gas. The objective of this case report is to highlight the potential exposure to phosphorus trifluoride gas and discuss the best management of it. A 48-year-old worker at a specialty gases laboratory was transported to the community Emergency Department (ED) in respiratory distress, presenting with peripheral cyanosis, an unobtainable oxygen saturation, chocolate-colored blood, and a Glasgow coma scale of 15. A non-rebreather was placed, poison control was contacted, and the patient was administered empiric methylene blue intravenously due to worsening cyanosis and respiratory distress. Upon arrival at the academic facility, the patient was no longer cyanotic and reported improvement of his symptoms. The patient's employer informed staff that a canister of phosphorus trifluoride gas in his workstation was found to be empty but should have been full. It was also discovered that a coworker left work early the same day with similar but milder symptoms. Hyperbaric oxygen therapy was considered; however, the patient was improving on oxygen via non-rebreather, and he had no other indications. Because the patient continued to require supplemental oxygen to maintain their oxygen saturation above 92%, he was admitted to the ICU and treated with prednisone daily for chemical pneumonitis. After 4 days, he successfully transitioned to room air without hypoxia. While exposures such as this do not occur frequently, it is important to maintain a broad differential and treatment plan as we continue to investigate the etiology and best treatment option.
AuthorsGary Fennema, Michelle Bates, Hayden Fox, David Gearhart, Brianne Roepke, Kelly Murray
JournalThe American journal of emergency medicine (Am J Emerg Med) Vol. 53 Pg. 282.e5-282.e6 (Mar 2022) ISSN: 1532-8171 [Electronic] United States
PMID34538706 (Publication Type: Case Reports)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.
Chemical References
  • Phosphorus
  • Oxygen
Topics
  • Cyanosis (etiology)
  • Dyspnea (complications)
  • Humans
  • Hypoxia (chemically induced, therapy)
  • Male
  • Middle Aged
  • Oxygen
  • Phosphorus
  • Respiratory Distress Syndrome (chemically induced, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: